FDA approves GSK whooping cough booster

05/4/2005 | SeattlePI.com

With whooping cough making a surprise resurgence among older children and teens, the FDA approved a GlaxoSmithKline booster vaccine against the disease, intended primarily for adolescents. The firm's Boostrix will be administered as part of a shot that already contains vaccines against tetanus and diphtheria.

View Full Article in:

SeattlePI.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Director, Quality Regulatory Affairs
Cardinal Health
Chicago, IL
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC